Cas:1477-57-2 Win 18446 manufacturer & supplier

Chemical Name:Win 18446

CAS.NO:1477-57-2

Synonyms:2,2-dichloro-N-[8-[(2,2-dichloroacetyl)amino]octyl]acetamide;N,N’-Octane-1,8-diylbis(2,2-dichloroacetamide);Fertilysin;N,N’-1,8-Octanediylbis(2,2-dichloroacetamide);N,N’-1,8-Octanediylbis[2,2-dichloroacetamide];N,N’-Octamethylenebis(2,2-dichloroacetamide);Acetamide, N,N’-1,8-octanediylbis[2,2-dichloro-;N,N’-Octamethylenebis(dichloroacetamide);EINECS 216-033-0;N,N’-Octamethylenebis(2,2-dichloro-N-ethylacetamide);N,N’-Bis(dichloroacetyl)-1,8-octamethylenediamine

Molecular Formula:C₁₂H₂₀Cl₄N₂O₂

Molecular Weight:366.111

HS Code:2924199090

Physical and Chemical Properties:

Melting point:118-120ºC

Boiling point:530.2±50.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.503

PSA:58.20000

Exact Mass:364.027893

LogP:1.96

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,2-dichloro-N-[8-[(2,2-dichloroacetyl)amino]octyl]acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-Bis(dichloroacetyl)-1,8-octamethylenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fertilysin Use and application,Acetamide, N,N’-1,8-octanediylbis[2,2-dichloro- technical grade,usp/ep/jp grade.

Related News: In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation. Win 18446 manufacturer Matthew Cheung, Hong Kong��s No. 2 official, appealed to medical workers to reconsider. ��At this critical moment, I believe the general public would count on medical personnel to fight against the epidemic together, in the spirit of professionalism,�� he wrote in a blog post on Sunday. Win 18446 supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. Win 18446 vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. Win 18446 factory The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement.